Showing 1271-1280 of 23044 results for "".
A Case of Anti–GAD65 Autoimmune Musicogenic Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/a-case-of-anti-gad65-autoimmune-musicogenic-epilepsy/32144/This case highlights the importance of pursuing workup for autoimmune epilepsy in individuals who present with medically refractory epilepsy provoked by music.Treatment of Developmental/Epileptic Encephalopathy With Spike-Wave Activation in Sleep
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/treatment-of-developmentalepileptic-encephalopathy-with-spike-wave-activation-in-sleep/39968/Developmental/epileptic encephalopathy with spike-wave activation in sleep is a unique electroclinical entity accompanied by cognitive, developmental, or behavioral stagnation or regression.Can Social Networking Revolutionize Disease Management?
https://reachmd.com/programs/clinicians-roundtable/can-social-networking-revolutionize-disease-management/5412/For over a decade, patients have been turning to the Internet for health information and support. At least one new online venture gives patients the opportunity to access data about medications and therapies and their effects and outcomes. But this isn't clinical trial data. This is detailed, highlyThe Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/the-dos-and-donts-of-managing-pediatric-hidradenitis-suppurativa/54450/Pediatric HS is often underrecognized, especially in prepubertal children, leading to delayed treatment and preventable disease progression. Clinicians should adapt diagnostic criteria and proactively screen high-risk groups, such as patients with severe acne. Children with HS frequently have assocDouble-Class Refractory CLL in Community Practice: Current and Future Management
https://reachmd.com/programs/cme/double-class-refractory-cll-in-community-practice-current-and-future-management/39261/Explore expert-guided strategies for managing double-class-refractory CLL, including BTK resistance, treatment sequencing, and emerging therapeutic options.Case Review: Targets Are Met—Can You Stick the Landing?
https://reachmd.com/programs/cme/case-review-targets-are-metcan-you-stick-the-landing/51488/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Treat-to-Target: Are We There Yet?
https://reachmd.com/programs/cme/treat-to-target-are-we-there-yet/51485/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Switching Strategies: Switch or Stay—What’s Your Call?
https://reachmd.com/programs/cme/switching-strategies-switch-or-staywhats-your-call/51487/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Tailoring Treatment: Can You Select the Best Therapy?
https://reachmd.com/programs/cme/tailoring-treatment-can-you-select-the-best-therapy/51483/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Remission: Can You Prove It?
https://reachmd.com/programs/cme/remission-can-you-prove-it/51486/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.